Adagene (ADAG) had the highest return between December 29, 2023 and January 16, 2024 by a US stock with a market cap of $100M+, returning 121.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Adagene (ADAG) | 12/29/2023 - 1/16/2024 | 121.05% |
Clene (CLNNW) | 12/29/2023 - 1/16/2024 | 118.75% |
SEALSQ (LAES) | 12/29/2023 - 1/16/2024 | 108% |
Praxis Precision Medicines (PRAX) | 12/29/2023 - 1/16/2024 | 99.18% |
Mega Matrix (MPU) | 12/29/2023 - 1/16/2024 | 97.86% |
Akso Health Group ADR (AHG) | 12/29/2023 - 1/16/2024 | 95.83% |
Nuvve (NVVEW) | 12/29/2023 - 1/16/2024 | 86% |
Neurogene (NGNE) | 12/29/2023 - 1/16/2024 | 85.21% |
Alarum Technologies (ALAR) | 12/29/2023 - 1/16/2024 | 72.63% |
WM Technology (MAPSW) | 12/29/2023 - 1/16/2024 | 68.27% |
Flex (FLEX) | 12/29/2023 - 1/16/2024 | 63.14% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 12/29/2023 - 1/16/2024 | 56.22% |
QuantaSing Group Limited American Depositary Shares (QSG) | 12/29/2023 - 1/16/2024 | 53.89% |
Real Brokerage (REAX) | 12/29/2023 - 1/16/2024 | 47.8% |
Sana Biotechnology (SANA) | 12/29/2023 - 1/16/2024 | 45.87% |
Inhibikase Therapeutics (IKT) | 12/29/2023 - 1/16/2024 | 44.26% |
Alliance Entertainment Holding Corporation Class A Common Stock (AENT) | 12/29/2023 - 1/16/2024 | 42.41% |
NRx Pharmaceuticals (NRXPW) | 12/29/2023 - 1/16/2024 | 40.68% |
HomeStreet (HMST) | 12/29/2023 - 1/16/2024 | 38.84% |
Nkarta (NKTX) | 12/29/2023 - 1/16/2024 | 37.5% |
Ardelyx (ARDX) | 12/29/2023 - 1/16/2024 | 36.97% |
Establishment Labs (ESTA) | 12/29/2023 - 1/16/2024 | 35.2% |
Verastem (VSTM) | 12/29/2023 - 1/16/2024 | 34.51% |
ZIM Integrated Shipping Services (ZIM) | 12/29/2023 - 1/16/2024 | 34.44% |
Jiayin (JFIN) | 12/29/2023 - 1/16/2024 | 34.36% |
